General Information


We are a biotechnology company with an established track record of success in developing and commercializing molecular testing products as well as innovating in the field of precision medicine. We believe that we are a market-leading provider of in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making critical and timely medical decisions during various life stages, such as family planning, pregnancy, or navigating a complex disease diagnosis. 

Employees: 674
Founded: 2012
Contact Information
Address 4330 La Jolla Village Drive, Suite 200, San Diego, CA 92122, US
Phone Number (855) 293-2639
Web Address
View Prospectus: Progenity
Financial Information
Market Cap $677.4mil
Revenues $113.3 mil (last 12 months)
Net Income $-141.2 mil (last 12 months)
IPO Profile
Symbol PROG
Exchange NASDAQ
Shares (millions): 6.7
Price range $15.00 - $15.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Piper Sandler/ Wells Fargo Securities
CO-Managers Baird/ Raymond James/ BTIG
Expected To Trade: 6/19/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change